Valuation: DiaSorin S.p.A.

Market Cap 3.65B 4.21B 3.39B 3.13B 5.9B 402B 6B 40.18B 15.73B 200B 15.8B 15.46B 671B P/E 2026 *
19.9x
P/E 2027 * 17.5x
Enterprise Value 4.32B 4.98B 4.02B 3.7B 6.98B 475B 7.1B 47.54B 18.61B 236B 18.69B 18.29B 794B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.21x
Free-Float
37.17%
Yield 2026 *
1.9%
Yield 2027 * 1.99%
1 day+1.13%
1 week+4.50%
Current month+2.92%
1 month-0.03%
3 months+17.21%
6 months-2.30%
Current year+1.63%
1 week 63
Extreme 63
71.48
1 month 63
Extreme 63
71.78
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
08/01/26 Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+4.50%-18.62%-31.66% 4.21B
+5.75%+1.43%+237.13%+292.45% 20.2B
-1.46%+1.29%-43.72%-27.43% 9.76B
+1.00%-2.63%+40.59%+14.84% 6.58B
+6.71%+2.85%+255.36%-21.43% 6.28B
+2.01%+2.29%-15.04%-19.06% 5.66B
+3.21%+2.81%-45.46% - 4.55B
-6.84%-15.30%+57.97%+75.47% 3.86B
+2.20%+2.20%-17.00%-41.94% 2.83B
-6.70%-16.32%-47.98%+153.78% 1.34B
Average +0.70%-0.57%+40.32%+43.89% 6.53B
Weighted average by Cap. +2.33%-1.10%+91.55%+94.57%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.14B 1.05B 1.98B 135B 2.01B 13.49B 5.28B 66.97B 5.3B 5.19B 225B 1.3B 1.5B 1.21B 1.12B 2.1B 143B 2.14B 14.34B 5.62B 71.22B 5.64B 5.52B 239B
Net income 182M 210M 169M 156M 294M 20.04B 299M 2B 785M 9.95B 788M 771M 33.47B 205M 236M 191M 176M 331M 22.55B 337M 2.26B 883M 11.2B 887M 868M 37.66B
Net Debt 669M 770M 621M 573M 1.08B 73.54B 1.1B 7.36B 2.88B 36.52B 2.89B 2.83B 123B 539M 621M 501M 462M 870M 59.28B 886M 5.93B 2.32B 29.44B 2.33B 2.28B 99.01B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
31/07/26 69.74 +1.13% 48,286
30/07/26 €68.96 -2.68% 166,617
29/07/26 €70.86 +0.34% 279,951
28/07/26 €70.62 +5.28% 486,326
27/07/26 €67.08 +0.51% 168,973
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
68.96EUR
Average target price
70.45EUR
Spread / Average Target
+2.16%

Quarterly revenue - Rate of surprise